tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Advertisement

Ryvu Therapeutics SA (9Y4) Revenue

Compare
1 Followers

Ryvu Therapeutics SA Revenue

Ryvu Therapeutics SA had a revenue of 16.93M in the quarter ending Mar 31, 2025, with -33.71%. This bring the company's revenue in the last twelve months to 73.30M, Increased -5.99%. In the fiscal year ending Dec 31, 2024, Ryvu Therapeutics SA had annual revenue of 77.97M with 66.38% growth.
Revenue (ttm)
73.30M
Revenue Growth
P/S Ratio
1.94
Revenue/Employee
€237,707
Employees
328
Market Cap
€151.40M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
77.97M31.11M+166.38%
Dec 31, 2023
46.86M8.06M+120.76%
Dec 31, 2022
38.80M27.62M+346.89%
Dec 31, 2021
11.19M-4.23M+72.57%
Dec 31, 2020
15.41M-27.15M+36.21%
Dec 31, 2019
42.57M-34.64M+55.13%
Dec 31, 2018
77.21M-10.61M+87.91%
Dec 31, 2017
87.82M39.69M+182.45%
Dec 31, 2016
48.13M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis